- JP-listed companies
- RIBOMIC Inc.
- Balance sheet
RIBOMIC Inc.【JP:4591】Balance sheet
Market cap
¥4.4B
P/E ratio
-3.8x
Ribomics develops next-generation aptamer drugs using its proprietary RiboART System to treat unmet medical needs like achondroplasia and eye diseases.
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 3,337 | 1,860 | 1,784 | 1,581 | 1,414 | 1,602 | 3,338 | 2,902 | 2,825 | 2,100 | 1,837 |
| Marketable securities, current | - | - | 1,200 | 600 | 600 | 1,000 | 400 | 2,500 | 1,800 | 1,500 | 1,300 | 1,200 |
| Total cash & short-term investments | - | 3,337 | 3,060 | 2,384 | 2,181 | 2,414 | 2,002 | 5,838 | 4,702 | 4,325 | 3,400 | 3,037 |
| Total current assets | - | 3,387 | 3,113 | 2,433 | 2,240 | 2,502 | 2,176 | 6,050 | 4,908 | 4,542 | 3,507 | 3,148 |
| Property, plant and equipment, net | - | 20 | 54 | 48 | 46 | 26 | 56 | 31 | - | - | - | - |
| Marketable securities, non-current | - | 2 | 2 | - | - | - | - | - | - | - | - | - |
| Total non-current assets | - | 32 | 71 | 63 | 87 | 67 | 94 | 69 | 46 | 41 | 41 | 38 |
| Total assets | - | 3,420 | 3,183 | 2,496 | 2,327 | 2,569 | 2,270 | 6,120 | 4,954 | 4,584 | 3,547 | 3,186 |
| Total current liabilities | - | 157 | 144 | 57 | 100 | 86 | 89 | 117 | 261 | 199 | 156 | 142 |
| Total non-current liabilities | - | - | - | - | - | 1,000 | - | - | - | - | - | - |
| Total liabilities | - | 157 | 144 | 57 | 100 | 1,086 | 89 | 117 | 261 | 199 | 156 | 142 |
| Retained earnings | - | -2,454 | -2,777 | -3,424 | -4,177 | -5,014 | -5,869 | -7,056 | -1,685 | -1,653 | -1,024 | -2,043 |
| Stockholders' equity | 354 | 3,263 | 3,039 | 2,439 | 2,227 | 1,483 | 2,181 | 6,003 | 4,694 | 4,384 | 3,391 | 3,044 |